Workflow
CSE Bulletin: Consolidation - BioVaxys Technology Corp. (BIOV)
Newsfileยท2025-09-09 20:27

Toronto, Ontario--(Newsfile Corp. - Le 9 septembre/September 2025) - BioVaxys Technology Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the number of outstanding shares will be reduced to approximately 29,342,496 common shares. The name and symbol will not change. Please note that all open orders will be canceled at the close of business on September ...